Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors.
Herr MM, Balderman SR, Wallace PK, Zhang Y, Tario JD Jr, Buxbaum NP, Holtan S, Ross M, McCarthy PL, Betts B, Maslak P, Hahn TE. Herr MM, et al. Among authors: holtan s. Transplant Cell Ther. 2024 Aug;30(8):808.e1-808.e13. doi: 10.1016/j.jtct.2024.05.018. Epub 2024 May 25. Transplant Cell Ther. 2024. PMID: 38801976
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.
Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, Hamadani M, Arai S, Salhotra A, Perez-Simon JA, Alousi A, Choe H, Kwon M, Bermúdez A, Kim I, Socié G, Chhabra S, Radojcic V, O'Toole T, Tian C, Ordentlich P, DeFilipp Z, Kitko CL; AGAVE-201 Investigators. Wolff D, et al. N Engl J Med. 2024 Sep 19;391(11):1002-1014. doi: 10.1056/NEJMoa2401537. N Engl J Med. 2024. PMID: 39292927 Clinical Trial.
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.
Holtan SG, Bolaños-Meade J, Al Malki MM, Wu J, Kitko CL, Reshef R, Rezvani AR, Shaffer BC, Solh MM, Yao JM, Runaas L, Elmariah H, Larkin KT, El Jurdi N, Gooptu M, Loren AW, Hall AC, Alousi AM, Jamy O, Clark W, Kean L, Bhatt AS, Perales MA, Applegate K, Efebera YA, Leifer E, Jones RJ, Horowitz MM, Mattila D, Saber W, Hamadani M, Martens MJ. Holtan SG, et al. J Clin Oncol. 2025 Jan 3:JCO2400921. doi: 10.1200/JCO.24.00921. Online ahead of print. J Clin Oncol. 2025. PMID: 39752608
Frailty and pre-frailty associated with long-term diminished physical performance and quality of life in breast cancer and hematopoietic cell transplant survivors.
El Jurdi N, Te HS, Cao Q, Napurski C, Wang S, Robinson A, Arora M, ElHusseini H, He F, Niedernhofer LJ, Thyagarajan B, Prizment A, Holtan S, Blaes AH, Yousefzadeh MJ. El Jurdi N, et al. Among authors: holtan s. Aging (Albany NY). 2024 Sep 26;16(18):12432-12442. doi: 10.18632/aging.206109. Epub 2024 Sep 26. Aging (Albany NY). 2024. PMID: 39330993 Free PMC article.
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results.
Pidala J, Holtan SG, Walton K, Kim J, Cao B, Elmariah H, Mishra A, Bejanyan N, Nishihori T, Khimani F, Perez L, Faramand RG, Davila ML, McSain S, Pleskow J, Baron J, Anasetti C, Moran Segura C, Weisdorf DJ, Blazar BR, Miller JS, Bachanova V, El Jurdi N, Betts BC. Pidala J, et al. Among authors: holtan sg. Blood. 2024 Nov 28;144(22):2295-2307. doi: 10.1182/blood.2024024789. Blood. 2024. PMID: 39046783 Free PMC article. Clinical Trial.
Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation.
Dimitrov M, Merkle S, Cao Q, Tryon RK, Vercellotti GM, Holtan SG, Kao RL, Srikanthan M, Terezakis SA, Tolar J, Ebens CL. Dimitrov M, et al. Among authors: holtan sg. Transplant Cell Ther. 2024 Oct;30(10):1005.e1-1005.e17. doi: 10.1016/j.jtct.2024.07.007. Epub 2024 Jul 11. Transplant Cell Ther. 2024. PMID: 39002862 Clinical Trial.
Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.
Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Kazadi D, Halaweish H, Khan MH, Hoeschen A, Cao Q, Luo X, Kabage AJ, Lopez S, Ramamoorthy S, Holtan SG, Weisdorf DJ, Khoruts A, Staley C. Rashidi A, et al. Among authors: holtan sg. Cancer Res Commun. 2024 Jun 10;4(6):1454-1466. doi: 10.1158/2767-9764.CRC-24-0138. Cancer Res Commun. 2024. PMID: 38767452 Free PMC article. Clinical Trial.
194 results